| 2004 |
COP1 physically interacts with p53 and functions as an E3 ubiquitin ligase for p53 in vitro and in vivo, targeting p53 for ubiquitin-dependent proteasomal degradation independently of MDM2 or Pirh2, thereby inhibiting p53-dependent transcription and apoptosis. |
Co-immunoprecipitation, in vitro ubiquitination assay, siRNA knockdown, cell cycle analysis |
Nature |
High |
15103385
|
| 2006 |
Following DNA damage, ATM kinase phosphorylates COP1 on Ser387, triggering rapid COP1 autodegradation and nuclear-to-cytoplasmic redistribution, which disrupts the COP1-p53 complex, abrogates p53 ubiquitination, and allows p53 stabilization. |
In vitro kinase assay, site-directed mutagenesis, immunofluorescence, co-immunoprecipitation, ionizing radiation treatment |
Science |
High |
16931761
|
| 2011 |
COP1 constitutively targets c-Jun for ubiquitin-mediated degradation in vivo; Cop1 hypomorphic mice develop spontaneous malignancies with elevated c-Jun, and Cop1-deficient cell proliferation is c-Jun-dependent, establishing COP1 as a tumor suppressor acting through c-Jun/AP-1. |
Mouse genetic allelic series (hypomorphs), in vivo ubiquitination, western blot, genetic epistasis (c-Jun rescue), bone marrow transplantation |
The Journal of clinical investigation |
High |
21403399
|
| 2011 |
COP1 ubiquitinates and degrades the ETS transcription factors ETV1, ETV4, and ETV5; prostate cancer translocations remove the COP1-binding degron motifs from ETV1, rendering it ~50-fold more stable; COP1 deficiency in mouse prostate elevates ETV1 and produces hyperplasia and early PIN. |
Ubiquitination assays, co-immunoprecipitation, site-directed mutagenesis of degron motifs, mouse prostate-specific KO, protein stability assays |
Nature |
High |
21572435
|
| 2002 |
Mammalian COP1 binds ubiquitinated proteins in vivo and is itself ubiquitinated; it contains a leucine-rich nuclear export signal (NES) in the coiled-coil domain and a novel bipartite NLS bridged by the RING finger; disruption of the RING finger abolishes nuclear import. |
Mutagenesis, subcellular fractionation, immunofluorescence, co-immunoprecipitation |
BMC cell biology |
Medium |
12466024
|
| 2009 |
COP1 interacts with MTA1 and acts as its E3 ubiquitin ligase targeting it for proteasomal degradation; the RING motif is required for this activity. MTA1 in turn promotes COP1 autoubiquitination, creating a feedback loop; ionizing radiation disrupts this to stabilize MTA1. |
Co-immunoprecipitation, in vitro ubiquitination assay, RING-motif mutagenesis, siRNA knockdown, ionizing radiation treatment |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19805145
|
| 2010 |
COP1 functions as an E3 ubiquitin ligase for c-Jun in mammalian cancer cells; depletion of COP1 reduces c-Jun poly-ubiquitination and stabilizes c-Jun protein, contributing to invasive breast cancer; GSK3β phosphorylation of c-Jun is required for efficient COP1-mediated degradation. |
siRNA knockdown, co-immunoprecipitation, ubiquitination assay, GSK3β inhibitors, overexpression rescue |
Neoplasia |
Medium |
24027432
|
| 2010 |
14-3-3σ binds phosphorylated COP1 at Ser387 after DNA damage and promotes COP1 nuclear export through COP1's NES, leading to enhanced COP1 self-ubiquitination and preventing COP1-mediated p53 nuclear exclusion and degradation. |
Co-immunoprecipitation, immunofluorescence, site-directed mutagenesis (S387), nuclear export assay, ubiquitination assay |
Cancer research |
Medium |
20843328 21135113
|
| 2010 |
Trib2 contains a C-terminal COP1-binding domain; the COP1-binding site is required for Trib2 to degrade C/EBPα and induce AML; COP1 knockdown inhibits Trib2-mediated C/EBPα degradation, establishing COP1 as the E3 ligase recruited by Trib2 to degrade C/EBPα. |
Structure-function mutagenesis, in vivo bone marrow transplantation, COP1 knockdown, protein stability assay |
Blood |
High |
20805362
|
| 2013 |
COP1 acts as a ubiquitin ligase for C/EBPα and promotes its degradation in vivo; Trib1 is essential as a scaffold for this process; coexpression of COP1 accelerates Trib1-induced AML, and a ligase-deficient COP1 mutant abrogates leukemogenesis. |
Mouse bone marrow transplantation, in vivo ubiquitination assay, ligase-dead mutant, co-immunoprecipitation |
Blood |
High |
23884858
|
| 2015 |
COP1 directly interacts with the VP motif of p27Kip1 and functions as its E3 ubiquitin ligase, accelerating ubiquitin-mediated degradation of p27 to promote cancer cell proliferation. |
Co-immunoprecipitation, in vitro ubiquitination assay, VP motif interaction analysis, COP1 overexpression/knockdown |
Oncotarget |
Medium |
26254224
|
| 2015 |
COP1 (RFWD2) degrades ETV4 and ETV5 at the protein level in the developing lung epithelium; genetic deletion of Etv4/Etv5 rescues the branching morphogenesis defect of Rfwd2 lung-epithelium-specific KO mice, establishing epistasis. |
Conditional knockout mice, genetic epistasis (Etv loss-of-function rescue), protein-level analysis, western blot |
Proceedings of the National Academy of Sciences of the United States of America |
High |
27335464
|
| 2015 |
COP1 in pancreatic β-cells targets ETV1, ETV4, and ETV5 for degradation; β-cell-specific COP1 KO mice develop diabetes due to insulin granule docking defects fully rescued by genetic deletion of Etv1, Etv4, and Etv5. |
β-cell-specific conditional KO mice, genetic epistasis (triple ETV KO rescue), protein stability assays, insulin secretion assays, electron microscopy |
Cell |
High |
26627735
|
| 2016 |
COP1 binds the VP motif of ATGL and targets it for K48-linked polyubiquitination predominantly at Lys100, leading to proteasomal degradation; COP1 depletion in vivo ameliorates high-fat diet-induced liver steatosis. |
Co-immunoprecipitation, ubiquitination assay with K48-linkage specificity, site-directed mutagenesis (K100), adenovirus-mediated COP1 depletion in mouse liver |
Diabetes |
High |
27658392
|
| 2020 |
COP1 ubiquitin ligase controls c/EBPβ protein levels in microglia; COP1 deficiency leads to rapid c/EBPβ accumulation driving pro-inflammatory gene expression and complement-mediated neurotoxicity; single allele deletion of Cebpb prevents the phenotype in COP1-KO microglia. |
COP1 conditional KO in microglia, genetic epistasis (Cebpb heterozygous rescue), co-culture neurotoxicity assay, antibody blocking, mouse tau neurodegeneration model |
Cell |
High |
32795415
|
| 2021 |
COP1 deletion in cancer cells stabilizes C/ebpδ protein by blocking its proteasomal degradation; Trib2 functions as a scaffold linking COP1 and C/ebpδ, leading to C/ebpδ polyubiquitination; COP1 suppresses macrophage chemoattractant gene expression through this mechanism. |
In vivo CRISPR KO screen, proteomics, co-immunoprecipitation, ubiquitination assay, transcriptomics |
Cell |
High |
34582788
|
| 2020 |
COP1 directly interacts with FOXO4 through a VP motif on FOXO4 and promotes its ubiquitin-mediated proteasomal degradation; CSN6 enhances COP1 E3 ligase activity toward FOXO4, coupling EGF-PKB/Akt signaling to FOXO4 stability. |
Co-immunoprecipitation, ubiquitination assay, VP motif interaction mapping, siRNA knockdown |
Advanced science |
Medium |
33101846
|
| 2015 |
CSN6 interacts with p27Kip1 and facilitates COP1-mediated ubiquitin-dependent degradation of p27; COP1 promotes nuclear export of p27, accelerating its cytoplasmic degradation. |
Co-immunoprecipitation, ubiquitination assay, nuclear export analysis, COP1 overexpression/knockdown |
Cell cycle |
Medium |
25945542
|
| 2019 |
COP1 physically interacts with and ubiquitinates SIRT1, promoting its proteasomal degradation under lipotoxic conditions; TRB3 recruits COP1 to SIRT1 to facilitate this ubiquitination. |
Co-immunoprecipitation, western blot, ubiquitination assay, high-fat diet mouse model |
Experimental cell research |
Medium |
31125554
|
| 2020 |
Erk1/2 inactivation causes COP1 to be released from the nuclear envelope (where it is anchored via interaction with TPR, a nuclear pore component) into the nucleoplasm, leading to rapid degradation of COP1 substrates c-Jun, ETV4, and ETV5. |
siRNA knockdown, immunofluorescence, co-immunoprecipitation (COP1-TPR), MEK inhibitor treatment, ectopic expression rescue |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32041890
|
| 2022 |
COP1 drives GATA2 ubiquitination at K419/K424 for proteasomal degradation; GATA2 uses alternate BR1/BR2 motifs (not the canonical VP degron) to bind COP1; COP1-mediated GATA2 degradation suppresses AR expression, PCa cell growth, and castration resistance. |
Ubiquitination assay, site-directed mutagenesis (K419/K424), co-immunoprecipitation, COP1 overexpression/KO in cell and xenograft models |
Proceedings of the National Academy of Sciences of the United States of America |
High |
36251994
|
| 2023 |
Glucose-dependent CK2 O-GlcNAcylation impairs CK2 phosphorylation of CSN2, releasing CRL4 from the deneddylase CSN to assemble CRL4COP1 E3 ligase, which targets p53 for degradation and derepresses glycolytic enzymes, amplifying the Warburg effect. |
Biochemical reconstitution, co-immunoprecipitation, peptide inhibitor (P28) disruption of COP1-p53, conditional p53 KO mouse model, mass spectrometry |
Molecular cell |
High |
37390815
|
| 2021 |
COP1 and COP9 signalosome (CSN) antagonize each other for CRL4 assembly; IP6 assists CSN to compete with COP1 for CRL4, and disrupting IP6-CSN binding leads to increased CRL4COP1 assembly and ETV5 ubiquitination; ETV5 stabilization by CRL neddylation inhibition rescues hyperinsulinemia phenotypes. |
Co-immunoprecipitation, ubiquitination assay, neddylation inhibitor (MLN4924), knockin mice (Csn2K70E), human islet validation |
Nature communications |
High |
33911083
|
| 2019 |
Mammalian cryptochromes negatively regulate CRL4COP1 by interacting with Det1 (a subunit unique to CRL4COP1), preventing COP1 from joining the CRL4 complex and allowing COP1 substrates to accumulate; this mechanism suppresses glucocorticoid receptor transcriptional networks. |
Co-immunoprecipitation, substrate accumulation assay, cell-based and mouse liver functional assays |
Current biology |
Medium |
31155351
|
| 2013 |
COP1 interacts with FIP200 (a key autophagy regulator) in the cytoplasm; this interaction is enhanced by UV irradiation, and ectopic COP1 expression reduces a specific form of FIP200 protein. |
Yeast two-hybrid screen, GST pulldown, split-GFP colocalization, western blot |
BMC biochemistry |
Low |
23289756
|
| 2022 |
COP1 directly interacts with PCDH9 and promotes its K48-linked polyubiquitination and proteasomal degradation in glioma cells. |
Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence co-localization, ubiquitination assay with K48 linkage specificity |
Molecular neurobiology |
Medium |
35084653
|
| 2023 |
COP1 forms a CUL4B-DDB1-COP1 E3 ligase complex that targets UTX (KDM6A histone demethylase) for degradation; COP1 deficiency in mouse intestinal tissue causes UTX accumulation and restricts colorectal tumorigenesis. |
Co-immunoprecipitation, immunoblot, conditional Cop1 KO mouse intestinal model, AOM/DSS-induced CRC model |
Experimental hematology & oncology |
Medium |
37679762
|
| 2025 |
COP1 mediates K63-linked polyubiquitination of GH3.5 (an IAA-amino acid synthetase) without affecting its protein stability, instead inhibiting its enzymatic activity; this suppresses IAA conjugation to amino acids in darkness to promote hypocotyl elongation. |
In vitro ubiquitination assay with K63-linkage specificity, enzyme activity assay, co-immunoprecipitation, IAA metabolite quantification, genetic analysis |
Nature communications |
High |
40229271
|
| 2024 |
COP1 physically interacts with VIL1/VERNALIZATION5 (a Polycomb protein) and regulates light-dependent chromatin loop formation at growth-promoting genes; COP1 governs H3K27me3 deposition through VIL1 to repress these genes in darkness. |
Co-immunoprecipitation, chromatin loop assay (ChIA-PET/3C), histone modification analysis, genetic epistasis |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
38349881
|
| 2019 |
Crystal structures of VP motifs from UVR8 and HY5 bound to COP1's WD40 domain revealed competitive binding; photoactivated UVR8 uses high-affinity cooperative binding of its VP motif and photosensing core to displace HY5 from COP1, preventing HY5 ubiquitination. |
Crystal structure determination, quantitative binding assays, reverse genetics |
The EMBO journal |
High |
31304983
|
| 2022 |
Cryo-EM structure of UV-B-activated UVR8 in complex with COP1 revealed two-interface interactions; both interfaces are required for UVR8 to competitively displace HY5 from COP1-SPA; RUP2 dissociates UVR8 from COP1-SPA and facilitates UVR8 redimerization. |
Cryo-EM structure determination, in vitro reconstitution of UV-B signaling pathway, competitive binding assay |
Science advances |
High |
35442727
|
| 2024 |
RFWD2 (COP1) overexpression in mice causes autistic-like behaviors accompanied by reduced dendritic spine density and abnormal synaptic function in mPFC pyramidal neurons; impaired social behaviors are rescued by ETV5 expression in mPFC, establishing ETV5 as a key substrate mediating RFWD2 synaptic function. |
Knockin mouse model, behavioral assays, dendritic spine analysis, electrophysiology, ETV5 viral rescue |
Molecular psychiatry |
High |
38503925
|
| 2024 |
IL-37d promotes C/EBPβ ubiquitination degradation by facilitating COP1 recruitment to C/EBPβ, and also disrupts C/EBPβ DNA binding, thereby reducing neutrophil ATP generation and spontaneous migration. |
Co-immunoprecipitation, ubiquitination assay, Lewis lung carcinoma mouse model, IL-37d recombinant protein treatment |
Cell reports |
Medium |
38363681
|